abbvie.com (ABBV) - יתרות מזומנים למניה

סמל תאגידי ולוגו של abbvie.com (ABBV)

The immunology portfolio of AbbVie Inc. (ABBV) continues to generate profit even after the loss of several patents. Current liquidity per share confirms this resilience, with the indicator standing at 6.12. A flawless reputation in biotechnology and rigorous intellectual property protection provide the foundation for growth, allowing the behemoth to effectively curb the expansion of cheap generics and maintain high drug pricing power.

ABBV - מזומנים למניה Abbvie בטווח 04.07.2022 - 20.11.2026

פילוחים אנליטיים של חברת AbbVie (ABBV)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:AbbVie Inc.
מוצר מקורי של abbvie.com

To offset patent risks, AbbVie Inc. (ABBV) is implementing an aggressive M&A strategy that requires significant expenditures to integrate new biotech assets. By analyzing the cash per share chart, an investor can assess the volume of liquidity available per share, allowing for real-time tracking of the recovery speed of cash reserves and the determination of the balance between the business's financial stability and the potential for future dividend payments.